Appili Therapeutics (Appili Therapeutics) Beginning Cash Position : $0.29 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Appili Therapeutics Beginning Cash Position?

Appili Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2023 was $0.29 Mil.

Appili Therapeutics's quarterly Beginning Cash Position declined from Jun. 2023 ($1.86 Mil) to Sep. 2023 ($0.39 Mil) and declined from Sep. 2023 ($0.39 Mil) to Dec. 2023 ($0.29 Mil).

Appili Therapeutics's annual Beginning Cash Position increased from Mar. 2021 ($8.36 Mil) to Mar. 2022 ($8.74 Mil) but then declined from Mar. 2022 ($8.74 Mil) to Mar. 2023 ($4.87 Mil).

Appili Therapeutics Beginning Cash Position Historical Data

The historical data trend for Appili Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics Beginning Cash Position Chart

Appili Therapeutics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Beginning Cash Position

Get a 7-Day Free Trial

4.28

3.88

8.36

8.74

4.87

Appili Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															1.78	1.04	1.86	0.39	0.29

Appili Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Appili Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics (Appili Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (OTCPK:APLIF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

APLI:Canada

Address

1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8

Website

https://www.appilitherapeutics.com

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.